CLINICAL INFLAMMATION OF THE
Inflammatory bowel diseases (IBD), with the main types being Crohn’s disease and ulcerative colitis, are chronic diseases that are characterized by recurring phases of inflammation of different bowel areas. Colonoscopy is the gold standard for assessing disease activity. More recently, optoacoustic imaging has shown the potential to provide a non-invasive assessment of colon wall inflammation through a transabdominal scan. In 2021, a first multi-center regulatory trial, EUPHORIA, was initiated by iThera Medical.